Skip to main content

Press Releases and Ad-hoc Announcements

31 March 2020	PR: Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy	PDF
26 March 2020	PR: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal	PDF
19 March 2020	PR: Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update	PDF
04 March 2020	PR: Heidelberg Pharma AG: US patent rights granted for diagnosis and treatment of patients with TP53/RNA polymerase II deletion	PDF
24 February 2020	PR: Partner Magenta Therapeutics Presents Preclinical Data on Lead Clinical Candidate MGTA-117 Demonstrating Broad Tolerability and High Therapeutic Index	PDF
22 January 2020	AH: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder dievini	PDF

1
2
3
4
5